đ Plowing into a downturn
Plus: When âhealthâ is a hashtag.
Good morning, Quartz readers!
Suggested Reading
Hereâs what you need to know
Fed sees no ceiling in sight. Federal Reserve Chair Jerome Powell just warned of more frequent âsupply shocksâ and interest rates that stay higher for longer.
Still banking on a storm? Jamie Dimon, JPMorgan Chaseâs CEO, just said he isnât ruling out a recession â even after the U.S. and China reached a temporary tariff truce.
Meta just hit an AI roadblock. The tech company has delayed its latest AI model, known internally as âBehemoth,â raising questions about Metaâs AI investments.
Trump wants Apple to hang up on India. After the company shifted some production from China as a result of tariffs, the president said he doesnât want phones âbuilt in India.â
Walmart might raise some prices. The retail giant reported first-quarter sales that beat expectations but had a big warning: Price hikes could be coming as a result of tariffs.
Coinbase clashes with regulators. The SEC is looking into whether the cryptocurrency company misstated its user base when it claimed 100 million âverified users.â
Thatâs one costly crypto hack. Coinbaseâs cyber attack â where hackers breached the system by bribing employees â could cost the company $400 million.
Tesla sales under scrutiny. The automaker had people return leased cars so it could use them as robotaxis â but sold them instead to âjack up the priceâ of used cars.
Spending spree rattles investors. Nvidia-backed CoreWeave saw its stock tumble after its first earnings report since going public showed CapEx spending that exceeded forecasts.
Shoe-in for the market share. Dickâs Sporting Goods just announced itâs buying Foot Locker in a $2.4 billion deal, bringing together two American sports staples.
Oh, Deere
The green giant is waving red flags: Deere just posted a 16% decline in revenue and a 24% drop in profit for the second fiscal quarter. Profit in its crown jewel segment, Production & Precision Ag, was down a backbreaking 21%, and construction wasnât spared either â profits there nosedived 43%.
The companyâs updated outlook isnât any brighter. Deere now expects large ag equipment sales in North America to fall around 30% this year, citing high interest rates, weaker grain prices, and softening demand across construction markets. With capital-intensive purchases on pause, itâs clear customers are choosing to wait out economic uncertainty.
If you zoom out, youâll see that this isnât just one company stalling: Itâs a broader economic warning. Deere is a bellwether. The sharp slowdown in farm and construction equipment sales isnât just bad news for the company â itâs a warning sign that capital spending across agriculture, infrastructure, and industrial sectors is pulling back fast.
Deere is a proxy for an economic pulse in the industrial heart. And right now? That pulse is faint, and the price of horsepower is starting to weigh heavily. Quartzâs Catherine Baab has more on why capital spendingâs wheels might be coming off.
Kennedyâs cabinet of curiosities
In Trumpâs second term, Robert F. Kennedy Jr. is running the Department of Health and Human Services â and running it straight into wellness culture.
Heâs hired anti-vaxxers, pushed fringe food policies, and inspired states to ban fluoride. Meanwhile, the administration has gutted health funding and slashed tens of thousands of federal healthcare jobs, all while claiming to be detoxing America in the name of âMaking America Healthy Again.â
This isnât just policyâitâs a vibe shift.
Wellness has become a $2 trillion industry, fueled by pandemic-era distrust and Instagram science. Once crunchy and female-coded, wellness is now a tech-bro playground of biohacking, testosterone stacks, and plasma swaps.
Still, not everything is pseudoscience. Some creators are sharing smart, accessible health info â filling gaps left by an overstretched system. But as government, wellness, and ideology blur, the question remains: When everyoneâs selling âhealth,â whoâs actually protecting it? Madeline Fitzgerald has more on the new politics of protein, plasma, and pseudoscience.